[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335218-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335218-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prognostic-implications-of-immunohistochemistry-in-patients-with-endometrial-cancer","Prognostic implications of immunohistochemistry in patients with endometrial cancer","","Various histological cell types, high histological grade, extensive myometrial invasion, and lymphovascular involvement are established risk factors in endometrial cancer. Carriers of DNA mismatch repair gene mutations (MLH1, MSH2, MSH6, PMS2) show increased susceptibility to both endometrial and colorectal malignancies, with lifetime risk estimated at 40%–60%. This study assessed the prevalence of immunohistochemical markers and microsatellite instability, evaluating associations with patient characteristics and clinical outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-implications-of-immunohistochemistry-in-patients-with-endometrial-cancer/335218/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-implications-of-immunohistochemistry-in-patients-with-endometrial-cancer/335218.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which patient and tumor features are described as risk factors for endometrial cancer in the abstract?","Question",{"text":63,"@type":64},"The abstract identifies various histological cell types, high histological grade, extensive myometrial invasion, and lymphovascular involvement as recognized risk factors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What was the main purpose of the immunohistochemistry and microsatellite instability analysis?",{"text":68,"@type":64},"The research aimed to investigate the prevalence of specific immunohistochemical (IHC) markers and microsatellite instability, then explore associations with patient characteristics and clinical outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"What immunohistochemical markers showed significant correlations, according to the abstract?",{"text":72,"@type":64},"Significant correlations were observed when MSH2 and MSH6 were positive, indicating an association with chemotherapy and brachytherapy, while FIGO stage and tumor grade showed no statistically significant relationships.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335218,1790151179,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","ORIGINAL PAPER  \nR J M E  \nRomanian Journal of Morphology & Embryology  \n[http://www.rjme.ro/](http://www.rjme.ro/)  \nPrognostic implications of immunohistochemistry in patients with endometrial cancer  \nMARIA-BIANCA ANCA-STANCIU1–3), ANDREI MANU1–3), MARIA VICTORIA OLINCA4,5),  \nBOGDAN CĂTĂLIN COROLEUCĂ2,3), DIANA-ELENA COMANDAŞU2,3), CIPRIAN ANDREI COROLEUCĂ2,3), CĂLINA MAIER2,3), ELVIRA BRĂTILĂ2,3)  \n1) PhD Student, Doctoral School, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania  \n2) Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania  \n3) Department of Obstetrics and Gynecology, Prof. Dr. Panait Sîrbu Clinical Hospital of Obstetrics and Gynecology, Bucharest, Romania  \n4) Department of Anatomical Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania  \n5) Department of Anatomical Pathology, Prof. Dr. Panait Sîrbu Clinical Hospital of Obstetrics and Gynecology, Bucharest, Romania  \nAbstract  \nVarious histological cell types, high histological grade, extensive myometrial invasion, and the presence of lymphovascular involvement are recognized as risk factors for disease development. Individuals carrying mutations in MutL homolog 1 (MLH1), MutS homolog 2 (MSH2), MutS homolog 6 (MSH6), or postmeiotic segregation increased 2 (PMS2) genes face an increased susceptibility to both endometrial and colorectal malignancies, with a lifetime risk ranging from 40% to 60%. This research aimed to investigate the prevalence of specific immunohistochemical (IHC) markers and microsatellite instability in endometrial carcinomas and explore potential associations with patient characteristics and clinical outcomes. Out of 58 patients with comprehensive follow-up data, a subgroup of 21 cases underwent rigorous IHC evaluation, involving estrogen receptor (ER), progesterone receptor (PR), Ki67, MLH1, MSH2, MSH6, PMS2, and p53 markers. Statistical analysis, employing the χ2 (chisquared) test, was conducted to assess the connection between individual IHC markers and clinical outcomes, with particular emphasis on the influence of radiation, chemotherapy, or brachytherapy treatment, as well as the occurrence of recurrence or mortality. Notably, significant correlations were observed in cases where MSH2 and MSH6 exhibited positive results, indicating their association with the use of chemotherapy and brachytherapy. However, the analysis pertaining to International Federation of Gynecology and Obstetrics (FIGO) stage or tumor grade did not reveal any statistically significant relationships with these parameters.  \nKeywords: endometrial cancer, immunohistochemistry, radiotherapy, chemotherapy.  \n􀀕 Introduction  \nEndometrial carcinoma (EC) stands as the prevailing gynecological malignancy afflicting American women, and in 2022, it is estimated to have contributed to approximately 39 300 new cases and 6600 fatalities [1] . Many women with early-stage EC experience recurrence and eventually pass away from the illness, despite receiving definitive surgical treatment. Factors such as specific histological cell types, high histological grade, extensive myometrial invasion, and the involvement of lymphovascular pathways are established risk determinants for disease progression [2]. Obesity, unopposed estrogen states (such as polycystic ovarian syndrome), early menarche or late menopause and genetic cancer syndromes such as Lynch syndrome (LS) and Cowden syndrome are all risk factors for EC [3]. Conversely, protective factors against EC include experiencing multiple pregnancies (multiparity) and use of oral contraceptives. Of particular significance is LS, an inherited condition stemming from germline mutations within genes responsible for deoxyribonucleic acid (DNA) mismatch repair (MMR) . This syndrome accounts for approximately 3% of all instances of endometrial malignancies [2] . Individuals  \nharboring mutations in genes such as MutL homolog 1 (MLH1), Mut","cbCaik7aD2tUaPgG","https://ap.wps.com/l/cbCaik7aD2tUaPgG","pdf",3720979,"English","# Abstract\n# Introduction\n## Risk factors for endometrial carcinoma\n# Aim\n# Patients, Materials and Methods","[{\"question\":\"Which patient and tumor features are described as risk factors for endometrial cancer in the abstract?\",\"answer\":\"The abstract identifies various histological cell types, high histological grade, extensive myometrial invasion, and lymphovascular involvement as recognized risk factors.\"},{\"question\":\"What was the main purpose of the immunohistochemistry and microsatellite instability analysis?\",\"answer\":\"The research aimed to investigate the prevalence of specific immunohistochemical (IHC) markers and microsatellite instability, then explore associations with patient characteristics and clinical outcomes.\"},{\"question\":\"What immunohistochemical markers showed significant correlations, according to the abstract?\",\"answer\":\"Significant correlations were observed when MSH2 and MSH6 were positive, indicating an association with chemotherapy and brachytherapy, while FIGO stage and tumor grade showed no statistically significant relationships.\"}]","Prognostic implications of immunohistochemistry in patients with endometrial cancer | PDF",1790010197,23]